NIOX Group (LON:NIOX) Issues Earnings Results

NIOX Group (LON:NIOX) posted its quarterly earnings results on Wednesday. The company reported GBX 1.41 EPS for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%.

NIOX Group Price Performance

NIOX Group stock opened at GBX 69 on Thursday. NIOX Group has a 1 year low of GBX 53.84 and a 1 year high of GBX 76. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.94 and a current ratio of 4.60. The firm has a 50 day moving average price of GBX 65.69 and a 200 day moving average price of GBX 61.63. The company has a market cap of £290.40 million, a price-to-earnings ratio of 42.07 and a beta of 0.92.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.